TRILEPTAL Trademark

Trademark Overview

On Monday, May 2, 1994, a trademark application was filed for TRILEPTAL with the United States Patent and Trademark Office. The USPTO has given the TRILEPTAL trademark a serial number of 74519619. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, August 30, 2018. This trademark is owned by Ciba-Geigy Corporation. The TRILEPTAL trademark is filed in the Pharmaceutical Products category with the following description:

anti-epileptic drug
trileptal

General Information

Serial Number74519619
Word MarkTRILEPTAL
Filing DateMonday, May 2, 1994
Status800 - REGISTERED AND RENEWED
Status DateThursday, August 30, 2018
Registration Number2186101
Registration DateTuesday, September 1, 1998
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 14, 1995

Trademark Statements

Goods and Servicesanti-epileptic drug

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 18, 1994
Primary Code005
First Use Anywhere DateFriday, November 30, 1973
First Use In Commerce DateMonday, April 19, 1993

Trademark Owner History

Party NameNovartis Corporation
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCiba-Geigy Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502
Party NameCiba-Geigy Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502
Party NameCiba-Geigy Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502

Trademark Events

Event DateEvent Description
Thursday, August 30, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, August 30, 2018REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, August 30, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, August 30, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, August 22, 2018TEAS SECTION 8 & 9 RECEIVED
Friday, September 1, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 26, 2008REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, February 26, 2008REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, February 19, 2008ASSIGNED TO PARALEGAL
Thursday, February 14, 2008TEAS SECTION 8 & 9 RECEIVED
Wednesday, August 8, 2007CASE FILE IN TICRS
Saturday, December 4, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 18, 2004PAPER RECEIVED
Friday, February 6, 2004TEAS SECTION 8 & 15 RECEIVED
Tuesday, September 1, 1998REGISTERED-PRINCIPAL REGISTER
Monday, June 29, 1998ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 12, 1998ASSIGNED TO EXAMINER
Monday, June 8, 1998STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 21, 1998USE AMENDMENT FILED
Friday, January 30, 1998EXTENSION 5 GRANTED
Wednesday, December 3, 1997EXTENSION 5 FILED
Wednesday, July 2, 1997EXTENSION 4 GRANTED
Tuesday, June 3, 1997EXTENSION 4 FILED
Wednesday, January 29, 1997EXTENSION 3 GRANTED
Wednesday, December 4, 1996EXTENSION 3 FILED
Saturday, August 10, 1996EXTENSION 2 GRANTED
Friday, May 31, 1996EXTENSION 2 FILED
Thursday, February 22, 1996EXTENSION 1 GRANTED
Tuesday, December 5, 1995EXTENSION 1 FILED
Tuesday, June 6, 1995NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 14, 1995PUBLISHED FOR OPPOSITION
Friday, February 10, 1995NOTICE OF PUBLICATION
Friday, September 16, 1994APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 16, 1994ASSIGNED TO EXAMINER

Related Keywords

trileptal drug epileptic anti